Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Economic Evaluation of PCV21 Use in Populations with Increasing Serotype 4 Invasive Pneumococcal Disease in the US: An Attributable Fraction Threshold Analysis

Saved in:
Bibliographic Details
Published in:Infectious Diseases and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868553644677267456
collection WordPress RSS
FRELIP Feed Integration
container_title Infectious Diseases and Therapy
description
discipline_display Communicable Diseases, Epidemiology
discipline_facet Communicable Diseases, Epidemiology
format Online Article
RSS Article
genre Journal Article
id rss_article:79369
institution FRELIP
journal_source_facet Infectious Diseases and Therapy
last_indexed 2026-06-20T21:40:16.351Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Economic Evaluation of PCV21 Use in Populations with Increasing Serotype 4 Invasive Pneumococcal Disease in the US: An Attributable Fraction Threshold Analysis
Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
sub_discipline_display General
sub_discipline_facet General
subject_display Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
subject_facet Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
title Economic Evaluation of PCV21 Use in Populations with Increasing Serotype 4 Invasive Pneumococcal Disease in the US: An Attributable Fraction Threshold Analysis
title_alt Evaluación económica del uso de PCV21 en poblaciones con aumento de enfermedad neumocócica invasiva por serotipo 4 en EE. UU.: un análisis de umbral de fracción atribuible
Évaluation économique de l'utilisation du PCV21 dans les populations avec augmentation du sérotype 4 de la maladie pneumococcique invasive aux États-Unis : une analyse de seuil de fraction attribuable
Avaliação Econômica do Uso de PCV21 em Populações com Aumento da Doença Pneumocócica Invasiva do Sorotipo 4 nos EUA: Uma Análise de Limiar de Fração Atribuível
title_auth Economic Evaluation of PCV21 Use in Populations with Increasing Serotype 4 Invasive Pneumococcal Disease in the US: An Attributable Fraction Threshold Analysis
title_es_txt Evaluación económica del uso de PCV21 en poblaciones con aumento de enfermedad neumocócica invasiva por serotipo 4 en EE. UU.: un análisis de umbral de fracción atribuible
title_fr_txt Évaluation économique de l'utilisation du PCV21 dans les populations avec augmentation du sérotype 4 de la maladie pneumococcique invasive aux États-Unis : une analyse de seuil de fraction attribuable
title_full Economic Evaluation of PCV21 Use in Populations with Increasing Serotype 4 Invasive Pneumococcal Disease in the US: An Attributable Fraction Threshold Analysis
title_fullStr Economic Evaluation of PCV21 Use in Populations with Increasing Serotype 4 Invasive Pneumococcal Disease in the US: An Attributable Fraction Threshold Analysis
title_full_unstemmed Economic Evaluation of PCV21 Use in Populations with Increasing Serotype 4 Invasive Pneumococcal Disease in the US: An Attributable Fraction Threshold Analysis
title_pt_txt Avaliação Econômica do Uso de PCV21 em Populações com Aumento da Doença Pneumocócica Invasiva do Sorotipo 4 nos EUA: Uma Análise de Limiar de Fração Atribuível
title_short Economic Evaluation of PCV21 Use in Populations with Increasing Serotype 4 Invasive Pneumococcal Disease in the US: An Attributable Fraction Threshold Analysis
title_sort economic evaluation of pcv21 use in populations with increasing serotype 4 invasive pneumococcal disease in the us: an attributable fraction threshold analysis
topic Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
url https://link.springer.com/article/10.1007/s40121-026-01364-x